Lymphoma, Follicular
Showing 51 - 65 of 65
Lymphoma, Follicular Trial in Hackensack (Obatoclax mesylate, Rituximab)
Completed
- Lymphoma, Follicular
- Obatoclax mesylate
- Rituximab
-
Hackensack, New JerseyThe Cancer Center at Hackensack University Medical Center
Jul 20, 2016
Lymphoma, Follicular Trial in Iowa City (HuMax-CD20)
Withdrawn
- Lymphoma, Follicular
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Apr 20, 2015
Lymphoma, Small Cleaved-Cell, Follicular, Lymphoma, Large-Cell, Follicular, Lymphoma, Follicular Trial in United States
Withdrawn
- Lymphoma, Small Cleaved-Cell, Follicular
- +3 more
- Ibritumomab Tiuxetan
- Iodine I 131 Tositumomab
-
Iowa City, Iowa
- +7 more
Apr 15, 2015
Lymphoma, Follicular, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular Trial in United States
Terminated
- Lymphoma, Follicular
- +3 more
- rituximab
- Pixantrone (BBR 2778)
-
Tucson, Arizona
- +37 more
Jan 15, 2015
Lymphoma, Follicular Trial in United States (Bevacizumab, Rituximab)
Completed
- Lymphoma, Follicular
-
Jonesboro, Arkansas
- +21 more
Dec 11, 2014
Lymphoma, Follicular Trial in Buffalo (Ofatumumab, Cyclophosphamide, Doxorubicin)
Completed
- Lymphoma, Follicular
- Ofatumumab
- +4 more
-
Buffalo, New YorkGSK Investigational Site
Jun 26, 2014
Lymphoma, Follicular Trial in Durham (Bortezomib, Rituximab, Fludarabine)
Terminated
- Lymphoma, Follicular
- Bortezomib
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Apr 29, 2014
Lymphoma, Follicular Trial in Burbank, Dallas (Autologous FL vaccine)
Completed
- Lymphoma, Follicular
- Autologous FL vaccine
-
Burbank, California
- +2 more
Jan 29, 2014
Lymphoma, Follicular Trial in Southampton (Ofatumumab)
Completed
- Lymphoma, Follicular
-
Southampton, United KingdomGSK Investigational Site
Dec 12, 2013
Lymphoma, Follicular Trial in Puerto Rico, United States (Sargramostim (Leukine), Rituximab)
Terminated
- Lymphoma, Follicular
- Sargramostim (Leukine)
- Rituximab
-
Birmingham, Alabama
- +21 more
Dec 2, 2013
Lymphoma, Follicular, Lymphoma, Small Lymphocytic Trial in Houston (autologous human tumor-derived HSPPC-96)
Completed
- Lymphoma, Follicular
- Lymphoma, Small Lymphocytic
- autologous human tumor-derived HSPPC-96
-
Houston, TexasM.D. Anderson Cancer Center
Sep 6, 2012
Quality of Life and Costs inReal Life Setting in Treated With
Completed
- Lymphoma, Follicular
- Non-Hodgkin Lymphoma
- [90]Y-ibritumomab tiuxetan (Zevalin, BAY86-5128)
-
Many Locations, Belgium(unnamed)
Aug 23, 2010